San Jose, CA (PRWEB) February 22, 2012
Zensar Technologies, a leading provider of healthcare information technology solutions and BPO services, announced recently the availability of a new tool called iCAn (ICD Converter & Analyzer). The i-CAn tool is an integrated product which includes mapping, crosswalk, documentation updates and analysis to help healthcare providers facilitate the transition to ICD-10. iCAn automatically converts ICD codes from ICD-9 to ICD-10 and vice versa. The tool has the capability to accurately convert ICD codes using GEMs and custom mapping rules. i-CAn meets the mapping needs of the entire healthcare enterprise and can act as the single source of truth for code conversions.
“Zensar’s iCAn tool, and our other ICD-10 compliance services, are designed to assist healthcare providers in addressing one of the most sweeping changes to occur in health information management in more than 20 years,” said Krishna Ramaswami, Head of the Healthcare Vertical Business “In addition to iCAn, we also provide a four-phased approach that helps implement ICD-10 and speed compliance across all departments within a healthcare facility. If a facility has already completed any of our four steps, we will assist them with the remaining ones,” added Chu Rao who heads Zensar’s US Healthcare business.
The new iCAn tool is part of Zensar’s overall healthcare information technology offerings for both clinical and business applications that are designed to help providers deliver patient care in a connected, streamlined and a patient-centric environment. The company’s wide range of comprehensive solutions for all clinical and administrative systems allows healthcare providers to optimize workflow, improve efficiency, meet compliance mandates and enhance patient care.
Zensar’s service offerings are grouped under 3Cs Solutions: Care Compliance, Care Applications, and Connected Care.
About Zensar Technologies (http://www.zensar.com)
Zensar Technologies is among the top 20 software services providers from India. Zensar is the world's first enterprise-wide SEI CMM Level 5 Company and was also later certified as a CMMI Level 5 Company with industry expertise that spans Retail, Manufacturing, Banking, Insurance, Energy and Utilities, Media and Connected Services – Government, Education and Healthcare. An RPG Group company, Zensar has more than 6000 employees with sales and operations presence across US, UK, Germany, Sweden, Finland, Middle East, South Africa, Singapore, Australia, China and Japan. The Company delivers comprehensive services in mission-critical applications, enterprise applications, e-business, BPO and Knowledge Services. The Company has developed tools and methodologies, including the proprietary Solution Blue Print (SBP), which enables its clients with innovative business solutions and a rapid 'go-to-market' capability. The Company supports Fortune 500 clients with software business solutions that help them compete in the digital economy. For more information, visit us at http://www.zensar.com
Certain statements in this release concerning our future growth prospects are forward-looking statements which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property and general economic conditions affecting our industry. The Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.